Co-Diagnostics, Inc. (CODX) › Operating Cash FlowCo-Diagnostics, Inc. (CODX) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2016: -$1.31M2017: -$3.21M2018: -$4.08M2019: -$5.53M2020: $28.17M2021: $41.08M2022: $6.57M2023: -$22.08M2024: -$29.16M2025: -$29.14M-$29.14M2016Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$29.14M+0.1%2024-$29.16M-32.0%2023-$22.08M-436.2%2022$6.57M-84.0%2021$41.08M+45.9%2020$28.17M+609.8%2019-$5.53M-35.4%2018-$4.08M-27.0%2017-$3.21M-144.7%2016-$1.31M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share